TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Human Coagulation Factor VIII 1.2 Key Market Segments 1.2.1 Human Coagulation Factor VIII Segment by Type 1.2.2 Human Coagulation Factor VIII Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Human Coagulation Factor VIII Market Overview 2.1 Global Market Overview 2.1.1 Global Human Coagulation Factor VIII Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Human Coagulation Factor VIII Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Human Coagulation Factor VIII Market Competitive Landscape 3.1 Global Human Coagulation Factor VIII Sales by Manufacturers (2017-2022) 3.2 Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2017-2022) 3.3 Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Human Coagulation Factor VIII Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Human Coagulation Factor VIII Sales Sites, Area Served, Product Type 3.6 Human Coagulation Factor VIII Market Competitive Situation and Trends 3.6.1 Human Coagulation Factor VIII Market Concentration Rate 3.6.2 Global 5 and 10 Largest Human Coagulation Factor VIII Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Human Coagulation Factor VIII Industry Chain Analysis 4.1 Human Coagulation Factor VIII Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Human Coagulation Factor VIII Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Human Coagulation Factor VIII Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Human Coagulation Factor VIII Sales Market Share by Type (2017-2022) 6.3 Global Human Coagulation Factor VIII Market Size Market Share by Type (2017-2022) 6.4 Global Human Coagulation Factor VIII Price by Type (2017-2022) 7 Human Coagulation Factor VIII Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Human Coagulation Factor VIII Market Sales by Application (2017-2022) 7.3 Global Human Coagulation Factor VIII Market Size (M USD) by Application (2017-2022) 7.4 Global Human Coagulation Factor VIII Sales Growth Rate by Application (2017-2022) 8 Human Coagulation Factor VIII Market Segmentation by Region 8.1 Global Human Coagulation Factor VIII Sales by Region 8.1.1 Global Human Coagulation Factor VIII Sales by Region 8.1.2 Global Human Coagulation Factor VIII Sales Market Share by Region 8.2 North America 8.2.1 North America Human Coagulation Factor VIII Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Human Coagulation Factor VIII Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Human Coagulation Factor VIII Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Human Coagulation Factor VIII Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Human Coagulation Factor VIII Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Shire (Baxter) 9.1.1 Shire (Baxter) Human Coagulation Factor VIII Basic Information 9.1.2 Shire (Baxter) Human Coagulation Factor VIII Product Overview 9.1.3 Shire (Baxter) Human Coagulation Factor VIII Product Market Performance 9.1.4 Shire (Baxter) Business Overview 9.1.5 Shire (Baxter) Human Coagulation Factor VIII SWOT Analysis 9.1.6 Shire (Baxter) Recent Developments 9.2 Bayer 9.2.1 Bayer Human Coagulation Factor VIII Basic Information 9.2.2 Bayer Human Coagulation Factor VIII Product Overview 9.2.3 Bayer Human Coagulation Factor VIII Product Market Performance 9.2.4 Bayer Business Overview 9.2.5 Bayer Human Coagulation Factor VIII SWOT Analysis 9.2.6 Bayer Recent Developments 9.3 CSL 9.3.1 CSL Human Coagulation Factor VIII Basic Information 9.3.2 CSL Human Coagulation Factor VIII Product Overview 9.3.3 CSL Human Coagulation Factor VIII Product Market Performance 9.3.4 CSL Business Overview 9.3.5 CSL Human Coagulation Factor VIII SWOT Analysis 9.3.6 CSL Recent Developments 9.4 Pfizer 9.4.1 Pfizer Human Coagulation Factor VIII Basic Information 9.4.2 Pfizer Human Coagulation Factor VIII Product Overview 9.4.3 Pfizer Human Coagulation Factor VIII Product Market Performance 9.4.4 Pfizer Business Overview 9.4.5 Pfizer Human Coagulation Factor VIII SWOT Analysis 9.4.6 Pfizer Recent Developments 9.5 Grifols 9.5.1 Grifols Human Coagulation Factor VIII Basic Information 9.5.2 Grifols Human Coagulation Factor VIII Product Overview 9.5.3 Grifols Human Coagulation Factor VIII Product Market Performance 9.5.4 Grifols Business Overview 9.5.5 Grifols Human Coagulation Factor VIII SWOT Analysis 9.5.6 Grifols Recent Developments 9.6 Biogen 9.6.1 Biogen Human Coagulation Factor VIII Basic Information 9.6.2 Biogen Human Coagulation Factor VIII Product Overview 9.6.3 Biogen Human Coagulation Factor VIII Product Market Performance 9.6.4 Biogen Business Overview 9.6.5 Biogen Recent Developments 9.7 Octapharma 9.7.1 Octapharma Human Coagulation Factor VIII Basic Information 9.7.2 Octapharma Human Coagulation Factor VIII Product Overview 9.7.3 Octapharma Human Coagulation Factor VIII Product Market Performance 9.7.4 Octapharma Business Overview 9.7.5 Octapharma Recent Developments 9.8 NovoNordisk 9.8.1 NovoNordisk Human Coagulation Factor VIII Basic Information 9.8.2 NovoNordisk Human Coagulation Factor VIII Product Overview 9.8.3 NovoNordisk Human Coagulation Factor VIII Product Market Performance 9.8.4 NovoNordisk Business Overview 9.8.5 NovoNordisk Recent Developments 9.9 Greencross 9.9.1 Greencross Human Coagulation Factor VIII Basic Information 9.9.2 Greencross Human Coagulation Factor VIII Product Overview 9.9.3 Greencross Human Coagulation Factor VIII Product Market Performance 9.9.4 Greencross Business Overview 9.9.5 Greencross Recent Developments 9.10 Kedrion 9.10.1 Kedrion Human Coagulation Factor VIII Basic Information 9.10.2 Kedrion Human Coagulation Factor VIII Product Overview 9.10.3 Kedrion Human Coagulation Factor VIII Product Market Performance 9.10.4 Kedrion Business Overview 9.10.5 Kedrion Recent Developments 9.11 BPL 9.11.1 BPL Human Coagulation Factor VIII Basic Information 9.11.2 BPL Human Coagulation Factor VIII Product Overview 9.11.3 BPL Human Coagulation Factor VIII Product Market Performance 9.11.4 BPL Business Overview 9.11.5 BPL Recent Developments 9.12 Hualan Bio 9.12.1 Hualan Bio Human Coagulation Factor VIII Basic Information 9.12.2 Hualan Bio Human Coagulation Factor VIII Product Overview 9.12.3 Hualan Bio Human Coagulation Factor VIII Product Market Performance 9.12.4 Hualan Bio Business Overview 9.12.5 Hualan Bio Recent Developments 9.13 RAAS 9.13.1 RAAS Human Coagulation Factor VIII Basic Information 9.13.2 RAAS Human Coagulation Factor VIII Product Overview 9.13.3 RAAS Human Coagulation Factor VIII Product Market Performance 9.13.4 RAAS Business Overview 9.13.5 RAAS Recent Developments 10 Human Coagulation Factor VIII Market Forecast by Region 10.1 Global Human Coagulation Factor VIII Market Size Forecast 10.2 Global Human Coagulation Factor VIII Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Human Coagulation Factor VIII Market Size Forecast by Country 10.2.3 Asia Pacific Human Coagulation Factor VIII Market Size Forecast by Region 10.2.4 South America Human Coagulation Factor VIII Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Human Coagulation Factor VIII by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Human Coagulation Factor VIII Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Human Coagulation Factor VIII by Type (2022-2028) 11.1.2 Global Human Coagulation Factor VIII Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Human Coagulation Factor VIII by Type (2022-2028) 11.2 Global Human Coagulation Factor VIII Market Forecast by Application (2022-2028) 11.2.1 Global Human Coagulation Factor VIII Sales (K Units) Forecast by Application 11.2.2 Global Human Coagulation Factor VIII Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Human Coagulation Factor VIII Market Size (M USD) Comparison by Region (M USD) Table 5. Global Human Coagulation Factor VIII Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2017-2022) Table 7. Global Human Coagulation Factor VIII Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2021) Table 10. Global Market Human Coagulation Factor VIII Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Human Coagulation Factor VIII Sales Sites and Area Served Table 12. Manufacturers Human Coagulation Factor VIII Product Type Table 13. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Human Coagulation Factor VIII Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Human Coagulation Factor VIII Market Challenges Table 22. Market Restraints Table 23. Global Human Coagulation Factor VIII Sales by Type (K Units) Table 24. Global Human Coagulation Factor VIII Market Size by Type (M USD) Table 25. Global Human Coagulation Factor VIII Sales (K Units) by Type (2017-2022) Table 26. Global Human Coagulation Factor VIII Sales Market Share by Type (2017-2022) Table 27. Global Human Coagulation Factor VIII Market Size (M USD) by Type (2017-2022) Table 28. Global Human Coagulation Factor VIII Market Size Share by Type (2017-2022) Table 29. Global Human Coagulation Factor VIII Price (USD/Unit) by Type (2017-2022) Table 30. Global Human Coagulation Factor VIII Sales (K Units) by Application Table 31. Global Human Coagulation Factor VIII Market Size by Application Table 32. Global Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Units) Table 33. Global Human Coagulation Factor VIII Sales Market Share by Application (2017-2022) Table 34. Global Human Coagulation Factor VIII Sales by Application (2017-2022) & (M USD) Table 35. Global Human Coagulation Factor VIII Market Share by Application (2017-2022) Table 36. Global Human Coagulation Factor VIII Sales Growth Rate by Application (2017-2022) Table 37. Global Human Coagulation Factor VIII Sales by Region (2017-2022) & (K Units) Table 38. Global Human Coagulation Factor VIII Sales Market Share by Region (2017-2022) Table 39. North America Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Units) Table 40. Europe Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Human Coagulation Factor VIII Sales by Region (2017-2022) & (K Units) Table 42. South America Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Human Coagulation Factor VIII Sales by Region (2017-2022) & (K Units) Table 44. Shire (Baxter) Human Coagulation Factor VIII Basic Information Table 45. Shire (Baxter) Human Coagulation Factor VIII Product Overview Table 46. Shire (Baxter) Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Shire (Baxter) Business Overview Table 48. Shire (Baxter) Human Coagulation Factor VIII SWOT Analysis Table 49. Shire (Baxter) Recent Developments Table 50. Bayer Human Coagulation Factor VIII Basic Information Table 51. Bayer Human Coagulation Factor VIII Product Overview Table 52. Bayer Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Bayer Business Overview Table 54. Bayer Human Coagulation Factor VIII SWOT Analysis Table 55. Bayer Recent Developments Table 56. CSL Human Coagulation Factor VIII Basic Information Table 57. CSL Human Coagulation Factor VIII Product Overview Table 58. CSL Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. CSL Business Overview Table 60. CSL Human Coagulation Factor VIII SWOT Analysis Table 61. CSL Recent Developments Table 62. Pfizer Human Coagulation Factor VIII Basic Information Table 63. Pfizer Human Coagulation Factor VIII Product Overview Table 64. Pfizer Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Pfizer Business Overview Table 66. Pfizer Human Coagulation Factor VIII SWOT Analysis Table 67. Pfizer Recent Developments Table 68. Grifols Human Coagulation Factor VIII Basic Information Table 69. Grifols Human Coagulation Factor VIII Product Overview Table 70. Grifols Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. Grifols Business Overview Table 72. Grifols Human Coagulation Factor VIII SWOT Analysis Table 73. Grifols Recent Developments Table 74. Biogen Human Coagulation Factor VIII Basic Information Table 75. Biogen Human Coagulation Factor VIII Product Overview Table 76. Biogen Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Biogen Business Overview Table 78. Biogen Recent Developments Table 79. Octapharma Human Coagulation Factor VIII Basic Information Table 80. Octapharma Human Coagulation Factor VIII Product Overview Table 81. Octapharma Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Octapharma Business Overview Table 83. Octapharma Recent Developments Table 84. NovoNordisk Human Coagulation Factor VIII Basic Information Table 85. NovoNordisk Human Coagulation Factor VIII Product Overview Table 86. NovoNordisk Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. NovoNordisk Business Overview Table 88. NovoNordisk Recent Developments Table 89. Greencross Human Coagulation Factor VIII Basic Information Table 90. Greencross Human Coagulation Factor VIII Product Overview Table 91. Greencross Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Greencross Business Overview Table 93. Greencross Recent Developments Table 94. Kedrion Human Coagulation Factor VIII Basic Information Table 95. Kedrion Human Coagulation Factor VIII Product Overview Table 96. Kedrion Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Kedrion Business Overview Table 98. Kedrion Recent Developments Table 99. BPL Human Coagulation Factor VIII Basic Information Table 100. BPL Human Coagulation Factor VIII Product Overview Table 101. BPL Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. BPL Business Overview Table 103. BPL Recent Developments Table 104. Hualan Bio Human Coagulation Factor VIII Basic Information Table 105. Hualan Bio Human Coagulation Factor VIII Product Overview Table 106. Hualan Bio Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Hualan Bio Business Overview Table 108. Hualan Bio Recent Developments Table 109. RAAS Human Coagulation Factor VIII Basic Information Table 110. RAAS Human Coagulation Factor VIII Product Overview Table 111. RAAS Human Coagulation Factor VIII Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. RAAS Business Overview Table 113. RAAS Recent Developments Table 114. Global Human Coagulation Factor VIII Sales Forecast by Region (K Units) Table 115. Global Human Coagulation Factor VIII Market Size Forecast by Region (M USD) Table 116. North America Human Coagulation Factor VIII Sales Forecast by Country (2022-2028) & (K Units) Table 117. North America Human Coagulation Factor VIII Market Size Forecast by Country (2022-2028) & (M USD) Table 118. Europe Human Coagulation Factor VIII Sales Forecast by Country (2022-2028) & (K Units) Table 119. Europe Human Coagulation Factor VIII Market Size Forecast by Country (2022-2028) & (M USD) Table 120. Asia Pacific Human Coagulation Factor VIII Sales Forecast by Region (2022-2028) & (K Units) Table 121. Asia Pacific Human Coagulation Factor VIII Market Size Forecast by Region (2022-2028) & (M USD) Table 122. South America Human Coagulation Factor VIII Sales Forecast by Country (2022-2028) & (K Units) Table 123. South America Human Coagulation Factor VIII Market Size Forecast by Country (2022-2028) & (M USD) Table 124. Middle East and Africa Human Coagulation Factor VIII Consumption Forecast by Country (2022-2028) & (Units) Table 125. Middle East and Africa Human Coagulation Factor VIII Market Size Forecast by Country (2022-2028) & (M USD) Table 126. Global Human Coagulation Factor VIII Sales Forecast by Type (2022-2028) & (K Units) Table 127. Global Human Coagulation Factor VIII Market Size Forecast by Type (2022-2028) & (M USD) Table 128. Global Human Coagulation Factor VIII Price Forecast by Type (2022-2028) & (USD/Unit) Table 129. Global Human Coagulation Factor VIII Sales (K Units) Forecast by Application (2022-2028) Table 130. Global Human Coagulation Factor VIII Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Human Coagulation Factor VIII Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Human Coagulation Factor VIII Market Size (M USD), 2017-2028 Figure 5. Global Human Coagulation Factor VIII Market Size (M USD) (2017-2028) Figure 6. Global Human Coagulation Factor VIII Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Human Coagulation Factor VIII Market Size (M USD) by Country (M USD) Figure 11. Human Coagulation Factor VIII Sales Share by Manufacturers in 2020 Figure 12. Global Human Coagulation Factor VIII Revenue Share by Manufacturers in 2020 Figure 13. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Human Coagulation Factor VIII Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Coagulation Factor VIII Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Human Coagulation Factor VIII Market Share by Type Figure 18. Sales Market Share of Human Coagulation Factor VIII by Type (2017-2022) Figure 19. Sales Market Share of Human Coagulation Factor VIII by Type in 2021 Figure 20. Market Size Share of Human Coagulation Factor VIII by Type (2017-2022) Figure 21. Market Size Market Share of Human Coagulation Factor VIII by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Human Coagulation Factor VIII Market Share by Application Figure 24. Global Human Coagulation Factor VIII Sales Market Share by Application (2017-2022) Figure 25. Global Human Coagulation Factor VIII Sales Market Share by Application in 2021 Figure 26. Global Human Coagulation Factor VIII Market Share by Application (2017-2022) Figure 27. Global Human Coagulation Factor VIII Market Share by Application in 2020 Figure 28. Global Human Coagulation Factor VIII Sales Growth Rate by Application (2017-2022) Figure 29. Global Human Coagulation Factor VIII Sales Market Share by Region (2017-2022) Figure 30. North America Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Human Coagulation Factor VIII Sales Market Share by Country in 2020 Figure 32. U.S. Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Human Coagulation Factor VIII Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Human Coagulation Factor VIII Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Human Coagulation Factor VIII Sales Market Share by Country in 2020 Figure 37. Germany Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Human Coagulation Factor VIII Sales and Growth Rate (K Units) Figure 43. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Region in 2020 Figure 44. China Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Human Coagulation Factor VIII Sales and Growth Rate (K Units) Figure 50. South America Human Coagulation Factor VIII Sales Market Share by Country in 2020 Figure 51. Brazil Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Human Coagulation Factor VIII Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Human Coagulation Factor VIII Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Human Coagulation Factor VIII Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Human Coagulation Factor VIII Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Human Coagulation Factor VIII Market Share Forecast by Type (2022-2028) Figure 65. Global Human Coagulation Factor VIII Sales Forecast by Application (2022-2028) Figure 66. Global Human Coagulation Factor VIII Market Share Forecast by Application (2022-2028)

•Shire (Baxter) •Bayer •CSL •Pfizer •Grifols •Biogen •Octapharma •NovoNordisk •Greencross •Kedrion •BPL •Hualan Bio •RAAS